Alyeska Investment Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,000
Closed -$1.3M 679
2024
Q2
$1.3M Hold
100,000
0.01% 425
2024
Q1
$1.75M Buy
+100,000
New +$1.75M 0.01% 368
2023
Q4
Hold
0
615
2023
Q3
Hold
0
610
2023
Q2
Hold
0
592
2023
Q1
Hold
0
536
2020
Q3
Hold
0
589
2020
Q2
Sell
-49,560
Closed -$332K 557
2020
Q1
$332K Buy
+49,560
New +$332K 0.01% 320